313 related articles for article (PubMed ID: 29443552)
21. Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology.
Hrenak J; Paulis L; Simko F
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27447621
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways.
Zhang Y; Shang Z; Liu A
Amino Acids; 2021 Oct; 53(10):1533-1543. PubMed ID: 34494132
[TBL] [Abstract][Full Text] [Related]
23. Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER.
Goncalves GK; Scalzo S; Alves AP; Agero U; Guatimosim S; Reis AM
Am J Physiol Cell Physiol; 2018 Mar; 314(3):C310-C322. PubMed ID: 29167148
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1.
Li S; Zhu Z; Xue M; Yi X; Liang J; Niu C; Chen G; Shen Y; Zhang H; Zheng J; Zhao C; Liang Y; Cong W; Wang Y; Jin L
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1241-1252. PubMed ID: 30677512
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes.
Dias-Peixoto MF; Santos RA; Gomes ER; Alves MN; Almeida PW; Greco L; Rosa M; Fauler B; Bader M; Alenina N; Guatimosim S
Hypertension; 2008 Sep; 52(3):542-8. PubMed ID: 18695148
[TBL] [Abstract][Full Text] [Related]
26. Nuclear import of Mas-related G protein-coupled receptor member D induces pathological cardiac remodeling.
Zhao K; Hua D; Yang C; Wu X; Mao Y; Sheng Y; Sun W; Li Y; Kong X; Li P
Cell Commun Signal; 2023 Jul; 21(1):181. PubMed ID: 37488545
[TBL] [Abstract][Full Text] [Related]
27. Phosphoproteomic studies of alamandine signaling in CHO-MrgD and human pancreatic carcinoma cells: An antiproliferative effect is unveiled.
da Silva FA; Rodrigues-Ribeiro L; Melo-Braga MN; Passos-Silva DG; Sampaio WO; Gorshkov V; Kjeldsen F; Verano-Braga T; Santos RAS
Proteomics; 2022 Sep; 22(17):e2100255. PubMed ID: 35652611
[TBL] [Abstract][Full Text] [Related]
28. Discovery and characterization of alamandine: a novel component of the renin-angiotensin system.
Lautner RQ; Villela DC; Fraga-Silva RA; Silva N; Verano-Braga T; Costa-Fraga F; Jankowski J; Jankowski V; Sousa F; Alzamora A; Soares E; Barbosa C; Kjeldsen F; Oliveira A; Braga J; Savergnini S; Maia G; Peluso AB; Passos-Silva D; Ferreira A; Alves F; Martins A; Raizada M; Paula R; Motta-Santos D; Klempin F; Pimenta A; Alenina N; Sinisterra R; Bader M; Campagnole-Santos MJ; Santos RA
Circ Res; 2013 Apr; 112(8):1104-11. PubMed ID: 23446738
[TBL] [Abstract][Full Text] [Related]
29. Alamandine attenuates arterial remodelling induced by transverse aortic constriction in mice.
de Souza-Neto FP; Silva MME; Santuchi MC; de Alcântara-Leonídio TC; Motta-Santos D; Oliveira AC; Melo MB; Canta GN; de Souza LE; Irigoyen MCC; Campagnole-Santos MJ; Guatimosim S; Santos RAS; da Silva RF
Clin Sci (Lond); 2019 Mar; 133(5):629-643. PubMed ID: 30737255
[No Abstract] [Full Text] [Related]
30. C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway.
Wu L; Gao L; Zhang D; Yao R; Huang Z; Du B; Wang Z; Xiao L; Li P; Li Y; Liang C; Zhang Y
Free Radic Biol Med; 2018 Jun; 121():215-230. PubMed ID: 29733904
[TBL] [Abstract][Full Text] [Related]
31. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
[TBL] [Abstract][Full Text] [Related]
32. Anti-hypertrophy effect of atorvastatin on myocardium depends on AMPK activation-induced miR-143-3p suppression via Foxo1.
Yu B; Liu D; Zhang H; Xie D; Nie W; Shi K; Yang P
Biomed Pharmacother; 2018 Oct; 106():1390-1395. PubMed ID: 30119211
[TBL] [Abstract][Full Text] [Related]
33. Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress.
Lin L; Liu X; Xu J; Weng L; Ren J; Ge J; Zou Y
J Cell Mol Med; 2016 Jan; 20(1):48-57. PubMed ID: 26515045
[TBL] [Abstract][Full Text] [Related]
34. Brown adipose tissue transcriptome unveils an important role of the Beta-alanine/alamandine receptor, MrgD, in metabolism.
Cerri GC; Santos SHS; Bader M; Santos RAS
J Nutr Biochem; 2023 Apr; 114():109268. PubMed ID: 36641071
[TBL] [Abstract][Full Text] [Related]
35. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
[TBL] [Abstract][Full Text] [Related]
36. Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase.
Stuck BJ; Lenski M; Böhm M; Laufs U
J Biol Chem; 2008 Nov; 283(47):32562-9. PubMed ID: 18790741
[TBL] [Abstract][Full Text] [Related]
37. Alamandine injected into the paraventricular nucleus increases blood pressure and sympathetic activation in spontaneously hypertensive rats.
Shen YH; Chen XR; Yang CX; Liu BX; Li P
Peptides; 2018 May; 103():98-102. PubMed ID: 29580957
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger.
Shah A; Gul R; Yuan K; Gao S; Oh YB; Kim UH; Kim SH
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1365-74. PubMed ID: 20190099
[TBL] [Abstract][Full Text] [Related]
39. Alamandine reverses hyperhomocysteinemia-induced vascular dysfunction via PKA-dependent mechanisms.
Qaradakhi T; Matsoukas MT; Hayes A; Rybalka E; Caprnda M; Rimarova K; Sepsi M; Büsselberg D; Kruzliak P; Matsoukas J; Apostolopoulos V; Zulli A
Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28901725
[TBL] [Abstract][Full Text] [Related]
40. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
